Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angioimmunoblastic lymphadenopathy with dysproteinemia

C E Freter1, J Cossman

  • 1Department of Medicine, Georgetown University Medical Center, Washington, DC 20007.

Seminars in Oncology
|December 1, 1993
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.

Current medicinal chemistry·2012
Same author

Drug development and the FDA's Critical Path Initiative.

Clinical pharmacology and therapeutics·2006
Same author

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002
Same author

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Gene expression analysis of single neoplastic cells and the pathogenesis of Hodgkin's lymphoma.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2001
Same author

Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.

Blood·2000